CHO Cell Line Development
KBI Biopharma can meet your needs for rapid cell line development with high productivity
KBI has extensive experience working with a variety of mammalian expression systems, including:
CHO-M Selexis SURETechnology™
CHO-DG44
CHO-ZN
CHO-S, CHO-K1 GS, and HEK293
Our competitive timeline can be as fast as 12 weeks from transfection to fully characterized RCB. Our platforms express a diverse range of molecules with high titers, including mAbs, bispecifics, Fc-fusions, recombinant proteins, ADCs, enzymes, glycoprotein vaccines, and biosimilars. Our clone stability assessment ensures expression and product quality beyond MCB generation.
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
